As of September 2024, PharmaCyte Biotech has a market cap of $28.65M. This makes PharmaCyte Biotech the world's 32012th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $40.34M | -4.17% |
2023 | $42.10M | -26.28% |
2022 | $57.10M | 17.20% |
2021 | $48.72M | -75.93% |
2020 | $202.40M | -83.46% |
2019 | $1.22B | 9.46% |
2018 | $1.12B | -33.69% |
2017 | $1.69B | -62.53% |
2016 | $4.50B | 223.70% |
2015 | $1.39B | -74.44% |
2014 | $5.44B | 76.47% |
2013 | $3.08B | - |